↓
 

Tag Archives: Foundation Medicine

Dr. Vince Miller, on the Weighty Decision of a Move to Industry, the Barriers to Molecular Marker Testing, and Disrupting the Pricing of Cancer Therapies | BTJ-018

Hosts Jack West and Charu Aggarwal meet with Dr. Vince Miller to discuss the process of deciding to move from academia to industry, the evolution of molecular marker testing, and the potential for EQRx to break the impasse of escalating cancer drug costs. (42:53)

Audio Podcast

Dr. Jack West: Exploring and Explaining the Shortcomings in Molecular Testing and Execution of Targeted Therapy

Host Jack West reviews the gulf between the best evidence-based cancer care guidelines & performance in broad clinical practice, exploring contributing factors & potential new models to improve US-based molecular oncology practice. (23:09)

Dr. Greg Riely (Pt 1): Current Practice & Challenges in Execution of Genomic Testing in Lung Cancer Treatment

Dr. Greg Riely from Memorial Sloan-Kettering Cancer Center (MSKCC) chats with Dr. Jack West about current standards in molecular testing for advanced NSCLC & potential challenges in execution in translating the promise of genomics into broad practice. (19:57)

Genomic Sequencing for All Solid Tumors: Where Will This Lead Us? (BMIC-019)

Dr. Jack West reviews the implications, both encouraging and potentially detrimental, of a recent FDA approval for broad genomic (NGS) testing of all solid tumors, ushering in a new era of growing precision medicine and molecular oncology. (8:55)

Download MP3 Audio Version

↑